Balyasny Asset Management Portfolio holdings
AUM
$44B
This Quarter Return
-19.39%
1 Year Return
+17.37%
3 Year Return
+72.12%
5 Year Return
+152.69%
10 Year Return
+378.29%
AUM
$7.6B
AUM Growth
+$7.6B
(-51%)
Cap. Flow
-$5.41B
Cap. Flow
% of AUM
-71.13%
Top 10 Holdings %
Top 10 Hldgs %
12%
Holding
1,552
New
478
Increased
213
Reduced
286
Closed
506
Top Buys
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
$89.6M |
| 2 |
Lowe's Companies
LOW
|
$86M |
| 3 |
Netflix
NFLX
|
$74.8M |
| 4 |
Dollar General
DG
|
$69.5M |
| 5 |
Intel
INTC
|
$67.4M |
Top Sells
| 1 |
American International
AIG
|
$193M |
| 2 |
RTX Corp
RTX
|
$170M |
| 3 |
PNC Financial Services
PNC
|
$126M |
| 4 |
Bank of America
BAC
|
$119M |
| 5 |
Union Pacific
UNP
|
$117M |
Sector Composition
| 1 | Healthcare | 15.66% |
| 2 | Technology | 15.56% |
| 3 | Financials | 15.02% |
| 4 | Consumer Discretionary | 14.41% |
| 5 | Industrials | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Melco Resorts & Entertainment
MLCO
$3.95B
| $31.4M | 0.37% |
2,533,192
+745,221
| +42% | +$9.24M |
|
|
TIF
52
DELISTED
Tiffany & Co.
TIF
| $31.4M | 0.37% |
242,303
-339,683
| -58% | -$44M |
|
53
BioMarin Pharmaceuticals
BMRN
$11.3B
| $31M | 0.37% |
366,292
-258,125
| -41% | -$21.8M |
|
54
Altice USA
ATUS
$1.12B
| $30.7M | 0.36% |
1,379,203
-879,106
| -39% | -$19.6M |
|
55
Akamai
AKAM
$11.1B
| $30.4M | 0.36% |
332,767
-172,732
| -34% | -$15.8M |
|
|
CONE
56
DELISTED
CyrusOne Inc Common Stock
CONE
| $30.3M | 0.36% |
+490,755
| New | +$30.3M |
|
57
Madison Square Garden
MSGS
$4.71B
| $30.3M | 0.36% |
143,166
+26,176
| +22% | +$5.53M |
|
58
CVS Health
CVS
$93B
| $30.1M | 0.36% |
507,297
+179,133
| +55% | +$10.6M |
|
59
DexCom
DXCM
$30.9B
| $29.5M | 0.35% |
109,586
-6,243
| -5% | -$1.68M |
|
60
Williams Companies
WMB
$70.5B
| $29.5M | 0.35% |
2,083,039
+1,985,799
| +2,042% | +$28.1M |
|
61
Altria Group
MO
$112B
| $29.2M | 0.35% |
+754,763
| New | +$29.2M |
|
62
Lam Research
LRCX
$124B
| $29.2M | 0.35% |
121,556
+6,435
| +6% | +$1.54M |
|
63
Blackrock
BLK
$170B
| $28.9M | 0.34% |
65,643
+50,877
| +345% | +$22.4M |
|
64
Allstate
ALL
$53.9B
| $28.7M | 0.34% |
+313,089
| New | +$28.7M |
|
65
Sanofi
SNY
$122B
| $28.4M | 0.34% |
650,092
+6,818
| +1% | +$298K |
|
66
Novo Nordisk
NVO
$252B
| $28.1M | 0.33% |
467,228
-229,764
| -33% | -$13.8M |
|
67
Archer Daniels Midland
ADM
$29.7B
| $27.5M | 0.33% |
782,180
+111,500
| +17% | +$3.92M |
|
68
ASML
ASML
$290B
| $27.4M | 0.33% |
104,813
+50,612
| +93% | +$13.2M |
|
|
CXO
69
DELISTED
CONCHO RESOURCES INC.
CXO
| $27.3M | 0.32% |
636,192
+301,300
| +90% | +$12.9M |
|
70
Ericsson
ERIC
$26.2B
| $27.3M | 0.32% |
+3,369,318
| New | +$27.3M |
|
|
XEC
71
DELISTED
CIMAREX ENERGY CO
XEC
| $25.8M | 0.31% |
1,535,792
+712,447
| +87% | +$12M |
|
72
AstraZeneca
AZN
$255B
| $25.5M | 0.3% |
570,747
+40,998
| +8% | +$1.83M |
|
73
US Bancorp
USB
$75.5B
| $25.5M | 0.3% |
739,023
+209,338
| +40% | +$7.21M |
|
74
Fortive
FTV
$15.9B
| $25.2M | 0.3% |
456,716
-77,948
| -15% | -$4.3M |
|
75
Hologic
HOLX
$14.7B
| $25.2M | 0.3% |
717,468
+584,185
| +438% | +$20.5M |
|